CN102276526B - Synthesis method of 2-amino pyridine compounds - Google Patents
Synthesis method of 2-amino pyridine compounds Download PDFInfo
- Publication number
- CN102276526B CN102276526B CN 201110224788 CN201110224788A CN102276526B CN 102276526 B CN102276526 B CN 102276526B CN 201110224788 CN201110224788 CN 201110224788 CN 201110224788 A CN201110224788 A CN 201110224788A CN 102276526 B CN102276526 B CN 102276526B
- Authority
- CN
- China
- Prior art keywords
- phenyl
- cyano group
- methoxy
- compounds
- pentadiene nitrile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001308 synthesis method Methods 0.000 title abstract 5
- 150000003930 2-aminopyridines Chemical class 0.000 title abstract 2
- 238000006243 chemical reaction Methods 0.000 claims abstract description 60
- -1 2,4-pentadiene nitrile compound Chemical class 0.000 claims abstract description 21
- 239000011541 reaction mixture Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 239000000758 substrate Substances 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 22
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 20
- 238000010189 synthetic method Methods 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 8
- 229940095054 ammoniac Drugs 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 229960003328 benzoyl peroxide Drugs 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 238000003756 stirring Methods 0.000 abstract description 19
- 239000002994 raw material Substances 0.000 abstract description 7
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 238000007086 side reaction Methods 0.000 abstract description 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 239000003054 catalyst Substances 0.000 abstract 2
- ICSNLGPSRYBMBD-UHFFFAOYSA-N alpha-aminopyridine Natural products NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 abstract 1
- 238000003912 environmental pollution Methods 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 16
- 238000004440 column chromatography Methods 0.000 description 15
- 239000012265 solid product Substances 0.000 description 15
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 13
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 5
- STSRVFAXSLNLLI-ONEGZZNKSA-N (2e)-penta-2,4-dienenitrile Chemical class C=C\C=C\C#N STSRVFAXSLNLLI-ONEGZZNKSA-N 0.000 description 4
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- YFQVSTNNJZZYLY-UHFFFAOYSA-N 2-amino-4,6-diphenylpyridine-3-carbonitrile Chemical compound N#CC=1C(N)=NC(C=2C=CC=CC=2)=CC=1C1=CC=CC=C1 YFQVSTNNJZZYLY-UHFFFAOYSA-N 0.000 description 2
- DTFPADSQKJTDTO-UHFFFAOYSA-N 2-amino-4-(4-chlorophenyl)-6-phenylpyridine-3-carbonitrile Chemical compound N#CC=1C(N)=NC(C=2C=CC=CC=2)=CC=1C1=CC=C(Cl)C=C1 DTFPADSQKJTDTO-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 150000003927 aminopyridines Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- JVVRJMXHNUAPHW-UHFFFAOYSA-N 1h-pyrazol-5-amine Chemical class NC=1C=CNN=1 JVVRJMXHNUAPHW-UHFFFAOYSA-N 0.000 description 1
- OOFICXDIKWEJFN-UHFFFAOYSA-N 2-amino-5-methyl-4,6-diphenylpyridine-3-carbonitrile Chemical compound CC1=C(C=2C=CC=CC=2)N=C(N)C(C#N)=C1C1=CC=CC=C1 OOFICXDIKWEJFN-UHFFFAOYSA-N 0.000 description 1
- FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical compound N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 description 1
- KCDNYRPDKSGQCM-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)-4-(pyrrolidine-1-carbonyl)piperidin-1-yl]-1-(4-fluorophenyl)butan-1-one Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCC(C=2C=C(Cl)C=CC=2)(C(=O)N2CCCC2)CC1 KCDNYRPDKSGQCM-UHFFFAOYSA-N 0.000 description 1
- WGOLHUGPTDEKCF-UHFFFAOYSA-N 5-bromopyridin-2-amine Chemical compound NC1=CC=C(Br)C=N1 WGOLHUGPTDEKCF-UHFFFAOYSA-N 0.000 description 1
- QUXLCYFNVNNRBE-UHFFFAOYSA-N 6-methylpyridin-2-amine Chemical compound CC1=CC=CC(N)=N1 QUXLCYFNVNNRBE-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- DQKWSXKCIHNLIE-UHFFFAOYSA-N COc(cc1)ccc1-c(cc(-c1ccccc1)nc1N)c1C#N Chemical compound COc(cc1)ccc1-c(cc(-c1ccccc1)nc1N)c1C#N DQKWSXKCIHNLIE-UHFFFAOYSA-N 0.000 description 1
- QRKGNMZBXLLNDY-KPKJPENVSA-N COc(cc1)ccc1C(/C=C/c1ccccc1)=C(C#N)C#N Chemical compound COc(cc1)ccc1C(/C=C/c1ccccc1)=C(C#N)C#N QRKGNMZBXLLNDY-KPKJPENVSA-N 0.000 description 1
- KFKBYBNHCZYXMF-UHFFFAOYSA-N COc1ccccc1-c(nc1N)ccc1C#N Chemical compound COc1ccccc1-c(nc1N)ccc1C#N KFKBYBNHCZYXMF-UHFFFAOYSA-N 0.000 description 1
- PAGDRHWLJHWADD-QPJJXVBHSA-N COc1ccccc1/C=C/C=C(C#N)C#N Chemical compound COc1ccccc1/C=C/C=C(C#N)C#N PAGDRHWLJHWADD-QPJJXVBHSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000004073 Dopamine D3 Receptors Human genes 0.000 description 1
- 108090000525 Dopamine D3 Receptors Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- COTGTGMFRJSGBS-IZZDOVSWSA-N N#CC(C#N)=C(/C=C/c1ccccc1)c(cc1)ccc1Cl Chemical compound N#CC(C#N)=C(/C=C/c1ccccc1)c(cc1)ccc1Cl COTGTGMFRJSGBS-IZZDOVSWSA-N 0.000 description 1
- SZOHWERSTQDQTH-VAWYXSNFSA-N N#CC(C#N)=C(/C=C/c1ccccc1)c1ccccc1 Chemical compound N#CC(C#N)=C(/C=C/c1ccccc1)c1ccccc1 SZOHWERSTQDQTH-VAWYXSNFSA-N 0.000 description 1
- UBSQTZVPBHBOBW-OWOJBTEDSA-N N#CC(C#N)=C/C=C/c(cc1)ccc1Cl Chemical compound N#CC(C#N)=C/C=C/c(cc1)ccc1Cl UBSQTZVPBHBOBW-OWOJBTEDSA-N 0.000 description 1
- CZLVTKWDKQMNPG-UHFFFAOYSA-N Nc1nc(-c(cc2)ccc2Cl)ccc1C#N Chemical compound Nc1nc(-c(cc2)ccc2Cl)ccc1C#N CZLVTKWDKQMNPG-UHFFFAOYSA-N 0.000 description 1
- 229940116355 PI3 kinase inhibitor Drugs 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 229940091171 VEGFR-2 tyrosine kinase inhibitor Drugs 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- NZKFNNAWWJMXTJ-UHFFFAOYSA-N [N+]1(=CC=CC=C1)[O-].N(=O)O[N+](=O)[O-] Chemical compound [N+]1(=CC=CC=C1)[O-].N(=O)O[N+](=O)[O-] NZKFNNAWWJMXTJ-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000005915 ammonolysis reaction Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 125000004119 disulfanediyl group Chemical group *SS* 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 229960001785 mirtazapine Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002935 phosphatidylinositol 3 kinase inhibitor Substances 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 229940067626 phosphatidylinositols Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110224788 CN102276526B (en) | 2011-08-08 | 2011-08-08 | Synthesis method of 2-amino pyridine compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110224788 CN102276526B (en) | 2011-08-08 | 2011-08-08 | Synthesis method of 2-amino pyridine compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102276526A CN102276526A (en) | 2011-12-14 |
CN102276526B true CN102276526B (en) | 2013-04-17 |
Family
ID=45102314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110224788 Expired - Fee Related CN102276526B (en) | 2011-08-08 | 2011-08-08 | Synthesis method of 2-amino pyridine compounds |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102276526B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013144191A1 (en) * | 2012-03-29 | 2013-10-03 | Bayer Intellectual Property Gmbh | Substituted 2-amino-3-cyanopyridines as inhibitors of sodium-calcium exchange and use thereof for cardiovascular diseases |
CN104447528B (en) * | 2014-11-15 | 2016-08-24 | 浙江大学 | The preparation method of pyridine-2,3-diethyl dicarboxylate |
CN108017577B (en) * | 2018-01-06 | 2019-03-01 | 怀化学院 | The process for catalytic synthesis of 2- pyridone |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4386209A (en) * | 1982-04-08 | 1983-05-31 | Reilly Tar & Chemical Corporation | Chichibabin reaction |
-
2011
- 2011-08-08 CN CN 201110224788 patent/CN102276526B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4386209A (en) * | 1982-04-08 | 1983-05-31 | Reilly Tar & Chemical Corporation | Chichibabin reaction |
Non-Patent Citations (5)
Title |
---|
Jianglei Hu et al..Temperature-Controlled Synthesis of Substituted Pyridine Derivatives via the [5C + 1N] Annulation of 1,1-Bisalkylthio-1,4-pentanedienes and Ammonium Acetate.《J.Org.Chem》.2008,第73卷2442-2445. |
Synthesis of 2-pyridinamines and heir alkyl derivatives from 2-cyanopyridines;戴立言等;《化工学报》;20070331;第58卷(第3期);670-672 * |
Temperature-Controlled Synthesis of Substituted Pyridine Derivatives via the [5C + 1N] Annulation of 1,1-Bisalkylthio-1,4-pentanedienes and Ammonium Acetate;Jianglei Hu et al.;《J.Org.Chem》;20080222;第73卷;2442-2445 * |
戴立言等.Synthesis of 2-pyridinamines and heir alkyl derivatives from 2-cyanopyridines.《化工学报》.2007,第58卷(第3期),670-672. |
毕锡和等.[5C+1N]成环反应:一种合成多取代2,3-二氢-4-吡啶酮的新方法.《有机化学》.2005,第25卷第92-93页. * |
Also Published As
Publication number | Publication date |
---|---|
CN102276526A (en) | 2011-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110317212B (en) | Synthesis of polycyclic carbamoylpyridone compounds | |
CN111675662B (en) | A kind of preparation method of quinazolinone compound substituted by 2-trifluoromethyl | |
CN102276526B (en) | Synthesis method of 2-amino pyridine compounds | |
Lange et al. | A New Flow Methodology for the Expedient Synthesis of Drug‐Like 3‐Aminoindolizines | |
JP2017521430A (en) | Method for producing aromatic primary diamine | |
JP5274256B2 (en) | Process for producing optically active β-hydroxy-α-aminocarboxylic acid ester | |
JP2015500248A (en) | Method for synthesizing 1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine-3-formamidine hydrochloride | |
CN103864637B (en) | A kind of N-(β-4-nitro alkyl) preparation method of amides | |
CN115260080B (en) | Preparation method of indole-3-formamide compound | |
CN105566162B (en) | The preparation technology of rilpivirine intermediate | |
Du et al. | Copper (II)-Catalyzed C–N Coupling of Aryl Halides and N-Nucleophiles Promoted by Quebrachitol or Diethylene Glycol | |
Yang et al. | Potassium hydroxide catalysed intermolecular aza-Michael addition of 3-cyanoindole to aromatic enones | |
CN107935997A (en) | A kind of difficult to understand this replaces the synthetic method of Buddhist nun | |
EP3307717B1 (en) | A novel process for preparing enzalutamide | |
CN108484509B (en) | One class has Boc aminobarbituric acid-cyclohexadiene spiro compound and its synthetic method | |
CN114276203B (en) | Method for synthesizing 2-aminobenzamide compound by ultraviolet light induction | |
Zhang et al. | Efficient one-pot synthesis of 2-alkylquinolines under solvent-free conditions using sulfonic acid functionalized ionic liquid as a recoverable and reusable catalyst | |
CN115353511A (en) | A kind of multi-component method for synthesizing carbonyl-bridged biheterocyclic compounds | |
CN108440373B (en) | Iron-catalyzed cyanoalkylindoline and preparation method thereof | |
US11767291B2 (en) | Preparation of secondary amines with electrophilic N-linchpin reagents | |
KR101521092B1 (en) | Process for the preparation of arylamide and enamide derivatives using organic axide and iridium catalyst | |
Kitamura et al. | Synthesis, structure, and reaction of chiral 2-azidoimidazolinium salts:(7aS)-3-azido-5, 6, 7, 7a-tetrahydro-2-[(1R)-1-phenylethyl]-1H-pyrrolo [1, 2-c] imidazolium hexafluorophosphate and 2-azido-1, 3-bis [(S)-1-phenylethyl] imidazolinium hexafluorophosphate | |
CN108530368A (en) | The method of organic base catalytic barbiturates and diene dintrile addition reaction | |
JP6175136B2 (en) | Method for preparing 2,2-difluoroethylamine derivatives by alkylating 2,2-difluoroethylamine | |
Al-Sehemi et al. | Selectivities in acylation of primary and secondary amine with diacylaminoquinazolinones and diacylanilines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Dong Dewen Inventor after: Xin Xiaoqing Inventor after: Liang Yongjiu Inventor after: Zhang Rui Inventor after: Xiang Dexuan Inventor after: Liu Xu Inventor after: Wang Zikun Inventor after: Yang Jiming Inventor before: Dong Dewen Inventor before: Xin Xiaoqing Inventor before: Liang Yongjiu Inventor before: Zhang Rui Inventor before: Xiang Dexuan Inventor before: Liu Xu Inventor before: Wang Zikun Inventor before: Yang Jiming |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130417 Termination date: 20150808 |
|
EXPY | Termination of patent right or utility model |